July 30, 2024: Study Links Active Ingredient in Some GLP-1 Drugs to Vision Loss June 17, 2024: Mounjaro Lawsuit Advances with First Status Conference Under New Judge Karen Marston June 9, 2024: Judge Karen Spence Marston to Preside Over Mounjaro Lawsuit May 20, 2024: Judge Change in Mounjaro Lawsuit Following Judge Pratters Death May 2, 2024: Mounjaro Lawsuit Science Day Scheduled for June 14, 2024 April 25, 2024: Mounjaro Lawsuit Initiated with Plaintiffs First Statement of the Case April 20, 2024: Mounjaro Lawsuits Still in Early Stages Mounjaro Lawsuits Still in Early Stages To date, the lawsuits against the maker of Mounjaro are still in the early stages of litigation
They have not been evaluated by the Food and Drug Administration, and are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety
Target: mid-range for age and sex, not above upper limit
It attracts immune cells, builds new blood vessels, and stimulates the growth factors your body needs to rebuild tissue faster and better
References Vakov J, Koan L, Vako L, Perjsi P
The implications are far wider
